Migraines

Neurology
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Trevena
TrevenaPA - Chesterbrook
1 program
1
Part A: TRV250-20mg/mlPhase 11 trial
Active Trials
NCT04201080Terminated9Est. Aug 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
TrevenaPart A: TRV250-20mg/ml

Clinical Trials (1)

Total enrollment: 9 patients across 1 trials

NCT04201080TrevenaPart A: TRV250-20mg/ml

A Trial to Evaluate the Efficacy, Safety and Tolerability of Subcutaneous TRV250

Start: Nov 2019Est. completion: Aug 20209 patients
Phase 1Terminated

Related Jobs in Neurology

Director, Distribution & Services

Xenon Pharmaceuticals
Remote
12h ago

Senior Medical Science Liaison (NYC Tri-State)

Xenon Pharmaceuticals
Remote
12h ago
$208K - $234K/yr

Director of Medical Affairs

CoMind
Miami, FL
13h ago

Director of Finance

CoMind
London, UK
13h ago

Electronics Engineering Manager

CoMind
London, UK
13h ago

Director of Information Technology

Zavation Medical Products
13h ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

Related Indications

Epilepsy(296)Multiple Sclerosis(283)Schizophrenia(268)Parkinson Disease(185)Alzheimer's Disease(179)Parkinson's Disease(163)Alzheimer Disease(119)Stroke(102)Depression(84)Relapsing-Remitting Multiple Sclerosis(84)